53 Current news about the topic molecular diagnostics
rss16-07-2012
Start-up financers High-Tech Gründerfonds and the investment company of Life Science Inkubator are investing together with the TTHU (Technology Transfer Heinrich Heine University GmbH) and a private investor in the development of molecular diagnostic cancer tests. Epivios GmbH, a spin-off of ...
02-11-2011
Lab21 Limited has announced that its Clinical Laboratory Division has extended its Clinical Pathology Accreditation (CPA) scope to include Molecular Biology and Virology in addition to Biochemistry. The accreditation was awarded by Clinical Pathology Accreditation (UK), the quality assurance ...
Series A financing round expanded to €34.1 million
31-10-2011
Curetis AG announced the expansion of its Series A financing round by € 9.6 million. The additional funds increase the round to a total of € 34.1 million and the total capital raised to date to € 36.6 million. The financing was led by Forbion Capital Partners together with Roche Venture Fund. ...
02-09-2011
Abbott announced the availability of a new molecular test in the European Union and New Zealand designed to identify the presence of gene rearrangements associated with a specific form of non-small-cell lung cancer (NSCLC). These rearrangements in a gene known as ALK (anaplastic lymphoma ...
Combining complementary platforms facilitates rapid and comprehensive discovery and development of biologically relevant markers
29-07-2011
Exonhit and BGI announced the successful completion of a project dedicated to expanding Exonhit’s Genome-Wide SpliceArrayTM to an additional strategic preclinical animal model species.To answer the need for a comprehensive understanding of gene deregulation and the expanding interest in ...
24-05-2011
The new real-time PCR device qTower from Analytik Jena AG was honored as "One of the best new devices in 2010" at this year's Annual Conference of China Scientific Instruments (ACCSI). "This award is an important signal for us in the current phase of the market introduction of our real-time ...
13-05-2011
By gaining certification according to the internationally recognized quality standard DIN EN ISO 13485 + AC:2009, ATLAS Biolabs GmbH has reached another milestone in its advances in the field of molecular diagnostics. DIN EN ISO 13485 + AC:2009 provides the criteria for quality management in ...
24-03-2011
SIRS-Lab announced the inclusion of the first patient in a 1000-patient clinical study evaluating their molecular pathogen test VYOO. The multicenter trial, performed in 11 key centers across Germany and initiated in February 2011, will deliver data about the utility of the PCR test compared ...
Co-development of assays and co-distribution of a fully integrated molecular platform due for launch in 2012
09-11-2010
bioMérieux and Biocartis announced that they have entered into a strategic agreement to co-develop assays on Biocartis’ fully integrated molecular diagnostics system, which the two companies will co-distribute starting in 2012. Under the agreement, bioMérieux will have worldwide exclusive ...
23-06-2010
Genetic Technologies Limited announced the appointment of Mr. Lewis Stuart as General Manager of its North American molecular diagnostics business. The new division is the result of the Company’s recent acquisition of US assets including BREVAGen™, a fully validated risk assessment test for ...
